Clinicopathological features and management of IgM multiple myeloma and Waldenstrom macroglobulinemia.

Sarosiek, S., Castillo, J. J., Hunter, Z. R., Branagan, A. R., & Treon, S. P. (2026). Clinicopathological features and management of IgM multiple myeloma and Waldenstrom macroglobulinemia.. Leukemia & Lymphoma, 1-8.

Abstract

Waldenström macroglobulinemia (WM) is the most common malignancy associated with an IgM paraprotein, but in rare cases, a clonal IgM may be the result of IgM multiple myeloma (IgM-MM). Although there are some overlapping features associated with these two entities, there are specific characteristics that can help differentiate IgM-MM from WM. In each patient a thorough clinical, pathologic, and genomic evaluation is required to distinguish these conditions and allow for accurate diagnosis and appropriate treatment.

Last updated on 04/01/2026
PubMed